The annual total of deaths from fungal disease worldwide has risen to 3.75 million, double the previous estimate, according to a new study.
Though fungal disease has multiple causes, the updated mortality figures nevertheless dwarf deaths from other single pathogens, killing six times more people than malaria, and almost three times as many than tuberculosis.
The work is the result of a collaboration of over 300 professionals across the world who contributed to published estimates for their country and individual fungal diseases.
Previous estimates were imprecise, argues Professor Denning, as many fungal disease exacerbate an existing disorder, itself often severe, such as leukemia or AIDS.
However according to the study, of the deaths linked to fungal disease, around 68%—or 2.55 million were likely to have been directly caused by it.
Around 1.2 million deaths (32%) had other underlying disease, with fungal disease contributing.
Around a third of 3.23 million chronic obstructive pulmonary disease (COPD) deaths worldwide are linked to infection with the fungus Aspergillus finds Professor Denning.
Though pulmonary tuberculosis was classified as the cause of death in 1.2 million people in 2019, as many as 340,000 (28%) of these could actually be fungal disease deaths he estimates.
Of the estimated 311,594 leukemia deaths globally in 2020, 14,000 (4.5%) could be attributable to aspergillosis, and some to other fungal infections they find.
Lung and bronchus cancer annual deaths stand at 1.8 million, with the new estimate indicating that aspergillosis is implicated in 49,000 deaths (2.7%) of them.
Candida— another type of fungal infection- is a serious problem in intensive care, complex surgical patients, diabetes, cancer and renal failure, as well as premature babies.
The researchers estimate that about 1.57 million people suffer from Candida bloodstream infection or invasive candidiasis with 995,000 deaths (63.6%), each year.
Professor Denning said, “This work is the first global comprehensive annual incidence estimate of fungal disease, yet many gaps and uncertainties remain.
“Our prior estimates of annual mortality were 1.5 to 2 million, yet we now find the probable number dying with or of a fungal infection is double this at about 3.75 million.
“This estimate was inspired by massive changes in fungal disease awareness and diagnostic capabilities driven by Global Action For Fungal Infections (GAFFI), working in partnership with The University of Manchester, the Fungal Infection Trust, CIFAR’s Fungal Kingdom: Threats and Opportunities program and GAFFI’s global Ambassador network.
“This work would also not have been possible without the remarkable collaboration of over 300 professionals across the world who contributed to published estimates for their country and individual fungal diseases.”
More information: David Denning, Global Incidence and Mortality of Severe Fungal Disease, The Lancet Infectious Diseases (2023). On SSRN: DOI: 10.2139/ssrn.4560971
News
Scientists Have Uncovered Previously Hidden Microbial Activity on Human Skin
The most abundant microbes on your skin may not be the ones doing most of the work. Human skin supports vast communities of bacteria, fungi, and viruses that can influence its protective barrier, immune [...]
Brazilian Tree Compounds Fight COVID-19 on Multiple Fronts
Scientists found compounds in a Brazilian tree that hit SARS-CoV-2 on multiple fronts, revealing a promising new lead in the search for COVID-19 treatments. Researchers have found that galloylquinic acids extracted from the leaves [...]
Cutting Two Amino Acids Slowed Prostate Cancer in Mice
A newly identified link between amino acid metabolism and cholesterol production may help prostate tumors adapt to hormone therapy. Prostate cancer can find ways around treatments designed to deprive tumors of the hormones they [...]
Largest-Ever Physics Survey Raises New Doubts About Our Model of the Universe
Physicists around the world remain deeply divided on key mysteries of the universe, from dark matter to quantum gravity. The standard cosmological model failed to gain majority support, and no leading theory dominated the [...]
Scientists Just Overturned a 100-Year-Old Belief About Bacteria in the Lungs
New findings raise questions about the role of microbes living in the lungs. More than 35 trillion bacteria live throughout the human body, forming microbiomes in the gut, mouth, lungs, skin, and urogenital tract. [...]
GHCE Concept
From the preface of the book Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artificial Intelligence, Edited by Frank Boehm: Since the publication of my first book (Nanomedical Device and Systems [...]
Novartis, Ionis drug failure spurs questions
Pelacarsen didn’t protect heart health despite lowering levels of a protein particle, “Lp(a),” in a large clinical trial — a result with important implications for cardiovascular drug research. Dive Brief: An RNA drug from [...]
New injectable treatment helps the brain rebuild after stroke
Biomedical engineers at Duke University have created an injectable biomaterial that may help the brain recover from damage left behind by an ischemic stroke. In experiments with mice, the material transformed the cavity created [...]
Scientists Discover a Hidden “Immune Organ” Inside the Skull
Researchers discovered lymph node-like immune hubs inside skull bone marrow that appear to act as rapid-response centers for the brain. For decades, the brain was thought to operate largely apart from the immune system. [...]
Engineered tRNAs and lipid nanoparticles target nonsense mutation cystic fibrosis
Researchers have developed a potential new approach for treating a form of cystic fibrosis caused by so-called nonsense mutations, combining chemically modified transfer RNAs with lipid nanoparticles designed to deliver the therapy directly to [...]
New pancreatic cancer drug carries a $39,800 monthly list price
A groundbreaking treatment for one of the most common forms of pancreatic cancer has been approved in pill form by the FDA. Revolution Medicines’ oral tablet daraxonrasib, branded as Rasonque, reduced the risk of [...]
Researchers Have Discovered a New Way To Reduce Chronic Nerve Pain
A cancer-linked protein called BRAF may help drive chronic nerve pain, and existing cancer drugs targeting it reduced pain sensitivity in preclinical models. Chronic nerve pain can persist long after an injury and often [...]
Our books now available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
Quantum-Enabled Regenerative Health: Reimagining Wellness, Precision Health and Longevity Medicine
Introduction Healthcare is approaching a frontier where the quantum portfolio could influence not only how disease is diagnosed and treated, but how health itself is measured, modeled, predicted and preserved. Quantum computing, quantum simulation, [...]
FDA Clears First-of-Its-Kind Nonmedication Treatment for PTSD
The FDA has cleared a system that uses brain activity data to personalize magnetic stimulation for PTSD, adding a new nonmedication treatment option. Every day in the United States, approximately 17.5 veterans die by suicide, [...]
FDA approves breakthrough drug to treat advanced pancreatic cancer
The Food and Drug Administration (FDA) approved on Wednesday a drug that could extend the survival of those with metastatic pancreatic cancer. The drug, called daraxonrasib, will be sold under the brand name Rasonque [...]
